Transplantation of human marrow stromal cells and mono-nuclear bone marrow cells into the injured spinal cord: A comparative study

Spine

Volumn 34, Issue 24, 2009, Pages 2605-2612

  Samdani, Amer F ^a   Paul, Courtney ^b   Betz, Randal R ^a   Fischer, Itzhak ^b   Neuhuber, Birgit ^b  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Autologous transplantation; Cell transplant; Immune response; Spinal cord injury

Indexed keywords

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL TRANSPLANTATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; MACROPHAGE; MALE; MICROGLIA; MONONUCLEAR CELL; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RAT; SCAR FORMATION; SPINAL CORD INJURY; STROMA CELL;

ANIMALS; BONE MARROW TRANSPLANTATION; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; CICATRIX; DISEASE MODELS, ANIMAL; FEMALE; GLIOSIS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; LEUKOCYTES, MONONUCLEAR; NERVE REGENERATION; NEUROGENESIS; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SPINAL CORD; SPINAL CORD INJURIES; STEM CELLS; STROMAL CELLS; YOUNG ADULT;

EID: 72849148521     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e3181bdca87     Document Type: Article

References (66)

1. DeVivo MJ, Vogel LC. Epidemiology of spinal cord injury in children and adolescents. J Spinal Cord Med 2004;27(suppl 1):S4 -10.
2. Vogel LC, Krajci KA, Anderson CJ. Adults with pediatric-onset spinal cord injury. Part 1: prevalence of medical complications. J Spinal Cord Med 2002; 25:106-116
3. Li S, Liu BP, Budel S, et al. Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury. J Neurosci 2004;24:10511-10520
4. Li W, Walus L, Rabacchi SA, et al. A neutralizing anti-Nogo66 receptor monoclonal antibody reverses inhibition of neurite outgrowth by central nervous system myelin. J Biol Chem 2004;279:43780-43788
5. Buchli AD, Schwab ME. Inhibition of Nogo: a key strategy to increase regeneration, plasticity and functional recovery of the lesioned central nervous system. Ann Med 2005;37:556-567
6. Li S, Kim JE, Budel S, et al. Transgenic inhibition of Nogo-66 receptor function allows axonal sprouting and improved locomotion after spinal injury. Mol Cell Neurosci 2005;29:26-39.
7. Cao Y, Shumsky JS, Sabol MA, et al. Nogo-66 receptor antagonist peptide (NEP1-40) administration promotes functional recovery and axonal growth after lateral funiculus injury in the adult rat. Neurorehabil Neural Repair 2008;22:262-278
8. Neumann S, Bradke F, Tessier-Lavigne M, et al. Regeneration of sensory axons within the injured spinal cord induced by intraganglionic cAMP elevation. Neuron 2002;34:885-893
9. Gao Y, Nikulina E, Mellado W, et al. Neurotrophins elevate cAMP to reach a threshold required to overcome inhibition by MAG through extracellular signal-regulated kinase-dependent inhibition of phosphodiesterase. J Neurosci 2003;23:11770-11777
10. Lu P, Yang H, Jones LL, et al. Combinatorial therapy with neurotrophins and cAMP promotes axonal regeneration beyond sites of spinal cord injury. J Neurosci 2004;24:6402-6409
11. Pearse DD, Pereira FC, Marcillo AE, et al. cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nat Med 2004;10:610-616
12. Behrman AL, Harkema SJ. Locomotor training after human spinal cord injury: a series of case studies. Phys Ther 2000;80:688-700.
13. Cai LL, Fong AJ, Otoshi CK, et al. Implications of assist-as-needed robotic step training after a complete spinal cord injury on intrinsic strategies of motor learning. J Neurosci 2006;26:10564-10568
14. Peterson CA, Murphy RJ, Dupont-Versteegden EE, et al. Cycling exercise and fetal spinal cord transplantation act synergistically on atrophied muscle following chronic spinal cord injury in rats. Neurorehabil Neural Repair 2000;14:85-91.
15. Beaumont E, Houle JD, Peterson CA, et al. Passive exercise and fetal spinal cord transplant both help to restore motoneuronal properties after spinal cord transection in rats. Muscle Nerve 2004;29:234-242
16. Barnabe-Heider F, Frisen J. Stem cells for spinal cord repair. Cell Stem Cell 2008;3:16-24.
17. Eftekharpour E, Karimi-Abdolrezaee S, Fehlings MG. Current status of experimental cell replacement approaches to spinal cord injury. Neurosurg Focus 2008;24:E19.
18. Louro J, Pearse DD. Stem and progenitor cell therapies: recent progress for spinal cord injury repair. Neurol Res 2008;30:5-16.
19. Murray M. Cellular transplants: steps toward restoration of function in spinal injured animals. Prog Brain Res 2004;143:133-146
20. Wrathall JR, Lytle JM. Stem cells in spinal cord injury. Dis Markers 2008; 24:239-250
21. Neuhuber B, Himes BT, Shumsky JS, et al. Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations. Brain Res 2005;1035:73-85.
22. Lu P, Jones LL, Tuszynski MH. BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury. Exp Neurol 2005;191:344-360
23. Ohta M, Suzuki Y, Noda T, et al. Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Exp Neurol 2004;187:266-278
24. Hofstetter CP, Schwarz EJ, Hess D, et al. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci USA 2002;99:2199-2204
25. Akiyama Y, Radtke C, Kocsis JD. Remyelination of the rat spinal cord by transplantation of identified bone marrow stromal cells. J Neurosci 2002; 22:6623-6630
26. Chopp M, Zhang XH, Li Y, et al. Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation. Neuroreport 2000;11:3001-3005
27. Himes BT, Neuhuber B, Coleman C, et al. Recovery of function following grafting of human bone marrow-derived stromal cells into the injured spinal cord. Neurorehabil Neural Repair 2006;20:278-296
28. Dasari VR, Spomar DG, Cady C, et al. Mesenchymal stem cells from rat bone marrow downregulate caspase-3-mediated apoptotic pathway after spinal cord injury in rats. Neurochem Res 2007;32:2080-2093
29. Bakshi A, Barshinger AL, Swanger SA, et al. Lumbar puncture delivery of bone marrow stromal cells in spinal cord contusion: a novel method for minimally invasive cell transplantation. J Neurotrauma 2006;23:55-65.
30. Chen X, Li Y, Wang L, et al. Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathology 2002;22: 275-279
31. Chen Q, Long Y, Yuan X, et al. Protective effects of bone marrow stromal cell transplantation in injured rodent brain: synthesis of neurotrophic factors. J Neurosci Res 2005;80:611-619
32. Hermann A, Gastl R, Liebau S, et al. Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells. J Cell Sci 2004; 117:4411-4422
33. Sanchez-Ramos JR, Song S, Cardozo-Pelaez F, et al. Adult bone marrow stromal cells differentiate into neural cell in vitro. Exp Neurol 2000;164: 247-256
34. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41-49
35. Reyes M, Verfaillie CM. Characterization of multipotent adult progenitor cells, a subpopulation of mesenchymal stem cells. Ann N Y Acad Sci 2001; 938:231-3; discussion: 233-235
36. Jin K, Greenberg DA. Tales of transdifferentiation. Exp Neurol 2003;183: 255-257
37. Lu P, Tuszynski MH. Can bone marrow-derived stem cells differentiate into functional neurons? Exp Neurol 2005;193:273-278
38. Neuhuber B, Gallo G, Howard L, et al. Reevaluation of in vitro differentiation protocols for bone marrow stromal cells: disruption of actin cytoskeleton induces rapid morphological changes and mimics neuronal phenotype. J Neurosci Res 2004;77:192-204.
39. Bakshi A, Hunter C, Swanger S, et al. Minimally invasive delivery of stem cells for spinal cord injury: advantages of the lumbar puncture technique. J Neurosurg Spine 2004;1:330-337
40. Paul C, Samdani A, Betz R, et al. Grafting of human bone marrow stromal cells into spinal cord injury: a comparision of delivery methods. Spine 2009; 34:328-334
41. Lennon DP, Haynesworth SE, Young RG, et al. A chemically defined medium supports in vitro proliferation and maintains the osteochondral potential of rat marrow-derived mesenchymal stem cells. Exp Cell Res 1995;219: 211-222
42. Glaser K, Limarzi LR, Poncher HG. Cellular composition of the bone marrow in normal infants and children. Pediatrics 1950;6:789-824.
43. Fernandez HF, Escalon MP, Pereira D, et al. Autotransplant conditioning regimens for aggressive lymphoma: are we on the right road? Bone Marrow Transplant 2007;40:505-513
44. Alyea E, Weller E, Schlossman R, et al. Outcome after autologous and allogeneic stem cell transplantation for patients with multiple myeloma: impact of graft-versus-myeloma effect. Bone Marrow Transplant 2003;32:1145-1151
45. Kiss TL, Sabry W, Lazarus HM, et al. Blood and marrow transplantation in elderly acute myeloid leukaemia patients-older certainly is not better. Bone Marrow Transplant 2007;40:405-416
46. Sirohi B, Powles R. Future challenges. Bone Marrow Transplant 2007;40: 1157-1164
47. Gardner SL, Carreras J, Boudreau C, et al. Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma. Bone Marrow Transplant 2008;41:867-872
48. Roifman CM, Somech R, Grunebaum E. Matched unrelated bone marrow transplant for T combined immunodeficiency. Bone Marrow Transplant 2008;41:947-952
49. Guggenheim R, Somech R, Grunebaum E, et al. Bone marrow transplantation for cartilage-hair-hypoplasia. Bone Marrow Transplant 2006;38: 751-756
50. Abdel-Latif A, Bolli R, Tleyjeh IM, et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 2007;167:989-997
51. Strauer BE, Brehm M, Schannwell CM. The therapeutic potential of stem cells in heart disease. Cell Prolif 2008;41(suppl 1):126-145
52. Yoshihara T, Ohta M, Itokazu Y, et al. Neuroprotective effect of bone marrow- derived mononuclear cells promoting functional recovery from spinal cord injury. J Neurotrauma 2007;24:1026-1036
53. Sykova E, Jendelova P, Urdzikova L, et al. Bone marrow stem cells and polymer hydrogels-two strategies for spinal cord injury repair. Cell Mol Neurobiol 2006;26:1113-1129
54. Callera F, do Nascimento RX. Delivery of autologous bone marrow precursor cells into the spinal cord via lumbar puncture technique in patients with spinal cord injury: a preliminary safety study. Exp Hematol 2006;34:130-131
55. Sykova E, Homola A, Mazanec R, et al. Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. Cell Transplant 2006;15:675-687
56. Saito F, Nakatani T, Iwase M, et al. Spinal cord injury treatment with intrathecal autologous bone marrow stromal cell transplantation: the first clinical trial case report. J Trauma 2008;64:53-59
57. Chernykh ER, Stupak VV, Muradov GM, et al. Application of autologous bone marrow stem cells in the therapy of spinal cord injury patients. Bull Exp Biol Med 2007;143:543-547
58. Park HC, Shim YS, Ha Y, et al. Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor. Tissue Eng 2005;11: 913-922
59. Yoon SH, Shim YS, Park YH, et al. Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: phase I/II clinical trial. Stem Cells 2007;25:2066-2073
60. Urdzikova L, Jendelova P, Glogarova K, et al. Transplantation of bone marrow stem cells as well as mobilization by granulocyte-colony stimulating factor promotes recovery after spinal cord injury in rats. J Neurotrauma 2006;23:1379-1391
61. Spees JL, Gregory CA, Singh H, et al. Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol Ther 2004;9:747-756
62. Parr AM, Tator CH, Keating A. Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant 2007;40:609-619
63. Kuh SU, Cho YE, Yoon DH, et al. Functional recovery after human umbilical cord blood cells transplantation with brain-derived neutrophic factor into the spinal cord injured rat. Acta Neurochir (Wien) 2005;147:985-92; discussion: 92.
64. Nishio Y, Koda M, Kamada T, et al. The use of hemopoietic stem cells derived from human umbilical cord blood to promote restoration of spinal cord tissue and recovery of hindlimb function in adult rats. J Neurosurg Spine 2006;5:424-433
65. Kao CH, Chen SH, Chio CC, et al. Human umbilical cord blood-derived CD34 cells may attenuate spinal cord injury by stimulating vascular endothelial and neurotrophic factors. Shock 2008;29:49-55.
66. Koda M, Okada S, Nakayama T, et al. Hematopoietic stem cell and marrow stromal cell for spinal cord injury in mice. Neuroreport 2005;16:1763-1767